| __timestamp | Bausch Health Companies Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 21226345 |
| Thursday, January 1, 2015 | 582800000 | 87718074 |
| Friday, January 1, 2016 | 455000000 | 93831530 |
| Sunday, January 1, 2017 | 366000000 | 79419009 |
| Monday, January 1, 2018 | 414000000 | 132166913 |
| Tuesday, January 1, 2019 | 471000000 | 89124838 |
| Wednesday, January 1, 2020 | 452000000 | 65782137 |
| Friday, January 1, 2021 | 465000000 | 88845513 |
| Saturday, January 1, 2022 | 529000000 | 134715000 |
| Sunday, January 1, 2023 | 604000000 | 180142000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bausch Health Companies Inc. and Intra-Cellular Therapies, Inc. have been at the forefront of this race. From 2014 to 2023, Bausch Health consistently outspent Intra-Cellular Therapies, with R&D expenses peaking at 604 million in 2023, a 145% increase from 2014. In contrast, Intra-Cellular Therapies, while spending less, showed a remarkable growth trajectory, with a 748% increase in R&D spending over the same period, reaching 180 million in 2023. This stark contrast highlights the different strategies these companies employ: Bausch Health's steady investment versus Intra-Cellular's aggressive growth. As the pharmaceutical landscape evolves, these spending patterns may well dictate the future of innovation and market leadership.
Comparing Innovation Spending: AbbVie Inc. and Bausch Health Companies Inc.
Novartis AG vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Bausch Health Companies Inc.
Cost Insights: Breaking Down Intra-Cellular Therapies, Inc. and Bausch Health Companies Inc.'s Expenses
Intra-Cellular Therapies, Inc. or Vericel Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs ImmunityBio, Inc.
Intra-Cellular Therapies, Inc. and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs MannKind Corporation: Strategic Focus on R&D Spending
R&D Insights: How Intra-Cellular Therapies, Inc. and Travere Therapeutics, Inc. Allocate Funds
Exelixis, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Bausch Health Companies Inc.
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Galapagos NV